Skip to main content
. Author manuscript; available in PMC: 2020 Oct 22.
Published in final edited form as: Biochemistry. 2017 Feb 13;56(8):1151–1162. doi: 10.1021/acs.biochem.6b01056

Figure 4.

Figure 4.

Inhibition of binding of various chain length heparin oligosaccharides to ZIKV E–HP. A mixture of ZIKV E and HP oligosaccharides (dp2–dp18) was injected over the surface of immobilized heparin at a flow rate of 30 μL/min. Binding of ZIKV E to immobilized HP was normalized on the basis of the RU obtained from a negative control (HBS-EP buffer). The error bars are standard deviations from triplicate experiments.